Fangjian Zhou

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park et al. · Annals of Oncology · 2023 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma

Chuangzhong Deng, Zaishang Li, Shengjie Guo et al. · OncoImmunology · 2016 · 67 citations · Full text

Life Sciences, Immunology, Oncology +17

Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines

Qiang-Hua Zhou, Chuang-Zhong Deng, Zai-Shang Li et al. · Cell Death and Disease · 2018 · 52 citations · Full text

Medicine, Genetics, Oncology +15

Up‐regulation of indoleamine 2,3‐dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients

Qiang‐hua Zhou, Hui Han, Jia-Bin Lu et al. · Cancer Communications · 2020 · 34 citations · Full text

Medicine, Oncology, Pathology +17

Novel variants in<i>MLL</i>confer to bladder cancer recurrence identified by whole-exome sequencing

Song Wu, Zhao Yang, Rui Ye et al. · Oncotarget · 2015 · 31 citations · Full text

Medicine, Genetics, Oncology +11